Search Results - Martikainen, Janne A., PhD (Health Econ)

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland

    Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland by Purmonen, Timo, MSc (Pharm), Martikainen, Janne A., MSc (Health Econ), Soini, Erkki J.O., BSc (Health Econ), Kataja, Vesa, MD, PhD, Vuorinen, Riikka-Liisa, BM, Kellokumpu-Lehtinen, Pirkko-Liisa, MD, PhD

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cost-Effectiveness of First-Line Chronic Lymphocytic Leukemia Treatments When Full-Dose Fludarabine Is Unsuitable

    Cost-Effectiveness of First-Line Chronic Lymphocytic Leukemia Treatments When Full-Dose Fludarabine Is Unsuitable by Soini, Erkki, MSc (health econ), Hautala, Anne, MSc (pharm), Poikonen, Eira, MD, PhD, Becker, Ursula, MSc, Kyttälä, Mira, PhD, Martikainen, Janne, PhD, Adjunct Professor

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Register-based predictors of adherence among new statin users in Finland

    Register-based predictors of adherence among new statin users in Finland by Aarnio, Emma J., MSc (Pharm), Martikainen, Janne A., PhD (Health Econ), Helin-Salmivaara, Arja, MD, PhD, Huupponen, Risto K., MD, PhD, Hartikainen, Juha E.K., MD, PhD, Peura, Piia K., MSc (Pharm), Korhonen, Maarit Jaana, PhD (Epid), LicSc (Pharm)

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: